Clinical Trials Browser

Phase 1 × Gastrointestinal Stromal Tumors × nilotinib × Clear all

NCT00135005 2020-12-08

Study of AMN107 With Imatinib in Gastrointestinal Stromal Tumors (GIST)

Phase 1 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00441155 2013-05-13

Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib

Phase 1 Completed

GastrointestinalSarcoma

Neoplasms, Gastrointestinal Stromal Tumors